HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

REACH Data-Sharing Conflicts Prompt Guidance From EU Chemicals Agency

This article was originally published in The Rose Sheet

Executive Summary

The European Chemicals Agency has published a protocol to address disputes between members of data-sharing groups under REACH, which speaks further to the challenges imposed on industry by Europe's chemicals law

You may also be interested in...



REACH Submission Process Improved As Deadline Creeps Closer

To help facilitate the submission of dossiers for the upcoming registration deadline under the European chemicals law (REACH), the European Chemicals Agency has introduced an improved submission process intended to speed up registration and authorization of chemicals

FDA Slacking In NDI Notification Enforcement; COVID-19 'Is Not An Excuse’ – NPA

In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.

CHPA Rebranding Reflects Growing Device Interests In Evolving Self-Care Market

The Consumer Healthcare Products Association’s rebranding initiative – its first in 20 years – aligns the group with today’s self-care marketplace where consumer medical devices play an increasingly prominent role. It also follows “landmark legislative achievements in 2020 that will further empower consumers to practice responsible self-care,” CHPA says.

UsernamePublicRestriction

Register

AP002434

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel